v3.25.2
SHARE- BASED COMPENSATION (Tables)
6 Months Ended
Jun. 30, 2025
Disclosure of terms and conditions of share-based payment arrangement [line items]  
Schedule of Expense Recognized in Financial Statements
   
Six months ended
June 30,
 
   
2025
   
2024
 
   
Unaudited
 
 
           
Share-based compensation - Attributable to equity holders of the Company
 
$
204
   
$
188
 
Share-based compensation - Attributable to non-controlling interests (*)
   
332
     
811
 
                 
   
$
536
   
$
999
 
Schedule of Number of Share Options
   
2025
   
2024
 
   
Number of options
   
Weighted average exercise prices ($)
   
Number of options
   
Weighted average exercise prices ($)
 
                         
Outstanding on January 1,
   
594,088
     
18.72
     
397,452
     
28.8
 
Granted
   
213,500
     
1.7
     
13,300
     
7.0
 
Exercised
   
-
     
-
     
-
     
-
 
Forfeited/Expired
   
(71,986
)
   
45.9
     
(2,938
)
   
121.1
 
                                 
Outstanding on June 30,
   
735,602
     
12.3
     
407,814
     
26.5
 
                                 
Exercisable at June 30,
   
323,683
     
24.7
     
314,648
     
30.7
 
Schedule of Number of Restricted Stock Units (RSU)
   
2025
   
2024
 
   
Number of RSUs
   
Weighted average grant date fair value
   
Number of RSUs
   
Weighted average grant date fair value
 
                         
Outstanding on January 1,
   
19,806
     
11.87
     
41,420
     
12.4
 
Granted
   
-
     
-
     
1,300
     
9.7
 
Vested
   
(4,991
)
   
15.7
     
(7,127
)
   
14.8
 
Forfeited/Expired
   
(2,135
)
   
12.0
     
(112
)
   
7.5
 
                                 
Outstanding on June 30,
   
12,680
     
10.4
     
35,481
     
11.8
 
Schedule of Compensation Cost of Equity-Based Awards
   
Six months ended
June 30,
 
     
2025 (*)
 
   
2024 (*)
 
   
Unaudited
 
                 
Cost of revenues
 
$
22
   
$
15
 
Research and development, net
   
155
     
213
 
Sales and marketing
   
71
     
129
 
General and administrative
   
224
     
260
 
                 
   
$
472
   
$
617
 
Employees Consultants and Directors [Member]  
Disclosure of terms and conditions of share-based payment arrangement [line items]  
Schedule of Assumptions Used to Value Options
   
2025
 
2024
 
           
Dividend yield (%)
 
-
 
-
 
Expected volatility of the share prices (%)
 
55
 
54
 
Risk-free interest rate (%)
 
4.46
 
4.21-4.24
 
Suboptimal factor
 
1.8-2
 
1.8-2
 
Post-vesting forfeiture rate (%)
 
5-20
 
 5-20
 
Subsidiaries’ options granted to employees, directors and consultants [Member]  
Disclosure of terms and conditions of share-based payment arrangement [line items]  
Schedule of Assumptions Used to Value Options
   
2025
 
2024
 
           
Dividend yield (%)
 
-
 
-
 
Expected volatility of the share prices (%)
 
76
 
79-83
 
Risk-free interest rate (%)
 
4.29
 
3.84-4.79
 
Suboptimal factor
 
2.0
 
1.8-2.0
 
Post-vesting forfeiture rate (%)
 
8-10
 
5-10
 
Schedule of Number of Restricted Stock Units (RSU)
   
2025
   
2024
 
   
Number of options
   
Weighted average exercise prices ($)
   
Number of options
   
Weighted average exercise prices ($)
 
                         
Outstanding on January 1,
   
1,718,194
     
2.06
     
2,531,134
     
1.63
 
Granted
   
16,500
     
1.00
     
138,500
     
1.46
 
Exercised
   
-
     
-
     
(5,000
)
   
0.19
 
Forfeited/Expired
   
(63,103
)
   
2.65
     
(748,576
)
   
0.21
 
                                 
Outstanding on June 30,
   
1,671,591
     
1.57
     
1,916,058
     
2.17
 
                                 
Exercisable at June 30,
   
1,168,344
     
1.88
     
1,037,638
     
2.01